 Colleen McIlvennan
Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 49 | 2023 | 485 | 11.180 |
Why?
| | Heart Failure | 65 | 2023 | 1969 | 8.510 |
Why?
| | Caregivers | 19 | 2023 | 709 | 4.030 |
Why?
| | Terminal Care | 10 | 2022 | 187 | 2.440 |
Why?
| | Decision Making | 15 | 2023 | 809 | 2.420 |
Why?
| | Heart Transplantation | 7 | 2021 | 671 | 1.630 |
Why?
| | Palliative Care | 7 | 2019 | 629 | 1.430 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 468 | 1.240 |
Why?
| | Choice Behavior | 2 | 2020 | 160 | 1.120 |
Why?
| | Quality of Life | 15 | 2023 | 2366 | 1.120 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 374 | 1.110 |
Why?
| | Delivery of Health Care | 4 | 2023 | 867 | 1.080 |
Why?
| | Cardiology | 2 | 2019 | 272 | 1.060 |
Why?
| | Patient Care Team | 3 | 2019 | 521 | 1.020 |
Why?
| | Thrombosis | 3 | 2021 | 309 | 0.980 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2020 | 1185 | 0.920 |
Why?
| | Stress, Psychological | 3 | 2021 | 972 | 0.900 |
Why?
| | Heart Injuries | 1 | 2023 | 38 | 0.880 |
Why?
| | Emotions | 6 | 2023 | 495 | 0.880 |
Why?
| | Physician-Patient Relations | 3 | 2020 | 490 | 0.840 |
Why?
| | Humans | 82 | 2023 | 118974 | 0.830 |
Why?
| | Registries | 5 | 2021 | 1810 | 0.830 |
Why?
| | Patient Participation | 6 | 2022 | 369 | 0.810 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 141 | 0.750 |
Why?
| | Palliative Medicine | 2 | 2017 | 13 | 0.740 |
Why?
| | Delirium | 1 | 2021 | 70 | 0.740 |
Why?
| | Patient Readmission | 2 | 2015 | 634 | 0.700 |
Why?
| | Biomedical Research | 3 | 2020 | 612 | 0.690 |
Why?
| | Middle Aged | 30 | 2023 | 27617 | 0.670 |
Why?
| | Health Literacy | 2 | 2022 | 169 | 0.660 |
Why?
| | Attitude to Death | 2 | 2016 | 61 | 0.660 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 687 | 0.660 |
Why?
| | Risk Assessment | 6 | 2020 | 3057 | 0.650 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 348 | 0.640 |
Why?
| | Coronavirus Infections | 2 | 2020 | 339 | 0.640 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.630 |
Why?
| | Hospice Care | 3 | 2016 | 174 | 0.610 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 19 | 0.600 |
Why?
| | Quality Improvement | 4 | 2021 | 963 | 0.600 |
Why?
| | Surveys and Questionnaires | 7 | 2021 | 4708 | 0.590 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 17 | 0.580 |
Why?
| | Patients | 2 | 2023 | 175 | 0.580 |
Why?
| | Hospital Records | 1 | 2016 | 11 | 0.580 |
Why?
| | Mexiletine | 1 | 2016 | 7 | 0.570 |
Why?
| | Hospitalization | 4 | 2021 | 1785 | 0.570 |
Why?
| | Amphetamine | 1 | 2016 | 23 | 0.570 |
Why?
| | Physicians | 4 | 2020 | 794 | 0.550 |
Why?
| | Male | 38 | 2023 | 57801 | 0.550 |
Why?
| | Substance Abuse Detection | 1 | 2016 | 63 | 0.540 |
Why?
| | Bereavement | 1 | 2016 | 49 | 0.540 |
Why?
| | Myocardial Infarction | 1 | 2023 | 968 | 0.540 |
Why?
| | Patient Preference | 5 | 2019 | 170 | 0.540 |
Why?
| | Cryosurgery | 1 | 2016 | 54 | 0.530 |
Why?
| | Aged | 21 | 2021 | 19657 | 0.530 |
Why?
| | Female | 38 | 2023 | 61565 | 0.520 |
Why?
| | Depression | 2 | 2021 | 1132 | 0.520 |
Why?
| | Transplant Recipients | 1 | 2016 | 148 | 0.520 |
Why?
| | Drug Monitoring | 1 | 2016 | 187 | 0.510 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 52 | 0.500 |
Why?
| | Patient-Centered Care | 4 | 2021 | 497 | 0.500 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 278 | 0.490 |
Why?
| | Heart Diseases | 2 | 2017 | 341 | 0.490 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 151 | 0.490 |
Why?
| | Adaptation, Psychological | 7 | 2023 | 557 | 0.480 |
Why?
| | Stroke Volume | 4 | 2023 | 513 | 0.480 |
Why?
| | Heart Ventricles | 4 | 2021 | 727 | 0.480 |
Why?
| | Decision Support Techniques | 4 | 2020 | 364 | 0.470 |
Why?
| | Advance Care Planning | 2 | 2017 | 191 | 0.470 |
Why?
| | Research Design | 1 | 2019 | 969 | 0.460 |
Why?
| | Qualitative Research | 5 | 2019 | 953 | 0.450 |
Why?
| | Blood Coagulation | 1 | 2014 | 219 | 0.440 |
Why?
| | Informed Consent | 1 | 2014 | 163 | 0.440 |
Why?
| | Pandemics | 2 | 2020 | 1355 | 0.440 |
Why?
| | Attitude to Health | 1 | 2016 | 410 | 0.430 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1129 | 0.420 |
Why?
| | Anticoagulants | 2 | 2021 | 559 | 0.400 |
Why?
| | Activities of Daily Living | 1 | 2014 | 354 | 0.390 |
Why?
| | Health Personnel | 2 | 2022 | 588 | 0.380 |
Why?
| | Adult | 19 | 2023 | 31512 | 0.360 |
Why?
| | United States | 12 | 2020 | 12555 | 0.350 |
Why?
| | Treatment Outcome | 8 | 2021 | 9342 | 0.320 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 1798 | 0.310 |
Why?
| | Substance-Related Disorders | 1 | 2016 | 971 | 0.310 |
Why?
| | Patient Education as Topic | 3 | 2018 | 699 | 0.300 |
Why?
| | Risk Factors | 9 | 2021 | 9000 | 0.300 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2020 | 1244 | 0.280 |
Why?
| | Withholding Treatment | 2 | 2016 | 67 | 0.270 |
Why?
| | Cost of Illness | 2 | 2020 | 258 | 0.270 |
Why?
| | Data Collection | 2 | 2019 | 658 | 0.250 |
Why?
| | Interviews as Topic | 3 | 2016 | 599 | 0.250 |
Why?
| | Communication | 3 | 2019 | 761 | 0.230 |
Why?
| | Troponin | 1 | 2023 | 47 | 0.230 |
Why?
| | Hospital Mortality | 2 | 2016 | 814 | 0.200 |
Why?
| | Trust | 1 | 2022 | 113 | 0.200 |
Why?
| | Home Nursing | 1 | 2020 | 27 | 0.190 |
Why?
| | Thoracentesis | 1 | 2019 | 7 | 0.180 |
Why?
| | BK Virus | 1 | 2019 | 15 | 0.180 |
Why?
| | Medicare | 2 | 2015 | 663 | 0.180 |
Why?
| | Biomarkers | 2 | 2023 | 3588 | 0.180 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 12 | 0.170 |
Why?
| | Data Accuracy | 1 | 2019 | 56 | 0.170 |
Why?
| | Motion Pictures | 1 | 2019 | 13 | 0.170 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 44 | 0.170 |
Why?
| | Viremia | 1 | 2019 | 132 | 0.170 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.170 |
Why?
| | Outpatients | 2 | 2023 | 325 | 0.170 |
Why?
| | Device Removal | 1 | 2020 | 127 | 0.170 |
Why?
| | Nurse Practitioners | 2 | 2019 | 107 | 0.170 |
Why?
| | Warfarin | 2 | 2021 | 139 | 0.160 |
Why?
| | Chronic Disease | 3 | 2022 | 1636 | 0.160 |
Why?
| | Research Support as Topic | 1 | 2019 | 114 | 0.160 |
Why?
| | Retrospective Studies | 10 | 2021 | 12978 | 0.160 |
Why?
| | Immunocompromised Host | 1 | 2019 | 200 | 0.160 |
Why?
| | Organ Transplantation | 1 | 2020 | 165 | 0.160 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 842 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2019 | 150 | 0.160 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 127 | 0.150 |
Why?
| | Spouses | 1 | 2018 | 88 | 0.150 |
Why?
| | Research Personnel | 1 | 2019 | 158 | 0.150 |
Why?
| | Prospective Studies | 3 | 2020 | 6471 | 0.150 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.150 |
Why?
| | Atropine | 1 | 2016 | 32 | 0.150 |
Why?
| | Loperamide | 1 | 2016 | 10 | 0.150 |
Why?
| | Antidiarrheals | 1 | 2016 | 15 | 0.150 |
Why?
| | Survival Rate | 2 | 2018 | 1720 | 0.150 |
Why?
| | Periodicals as Topic | 1 | 2019 | 191 | 0.150 |
Why?
| | Nursing Assessment | 1 | 2017 | 46 | 0.150 |
Why?
| | Pressure Ulcer | 1 | 2017 | 33 | 0.150 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 338 | 0.140 |
Why?
| | Cause of Death | 1 | 2018 | 380 | 0.140 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 265 | 0.140 |
Why?
| | Terminally Ill | 1 | 2016 | 33 | 0.140 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 5 | 0.140 |
Why?
| | Chromatography, Gas | 1 | 2016 | 31 | 0.140 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 20 | 0.140 |
Why?
| | Referral and Consultation | 1 | 2021 | 648 | 0.140 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 46 | 0.140 |
Why?
| | Patient Care Management | 1 | 2016 | 57 | 0.140 |
Why?
| | Prosthesis Design | 2 | 2016 | 285 | 0.140 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 58 | 0.140 |
Why?
| | Consumer Health Information | 1 | 2016 | 48 | 0.140 |
Why?
| | Mortality | 1 | 2018 | 299 | 0.140 |
Why?
| | Health Policy | 2 | 2020 | 333 | 0.140 |
Why?
| | Truth Disclosure | 1 | 2016 | 38 | 0.140 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 277 | 0.140 |
Why?
| | Canada | 1 | 2017 | 340 | 0.140 |
Why?
| | Drug Combinations | 1 | 2016 | 291 | 0.140 |
Why?
| | Uncertainty | 1 | 2016 | 101 | 0.130 |
Why?
| | Hospices | 1 | 2016 | 79 | 0.130 |
Why?
| | Workload | 1 | 2016 | 128 | 0.130 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 299 | 0.130 |
Why?
| | Mental Health | 1 | 2021 | 568 | 0.130 |
Why?
| | Social Security | 1 | 2015 | 4 | 0.130 |
Why?
| | Medical Indigency | 1 | 2015 | 10 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2023 | 2874 | 0.130 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 30 | 0.130 |
Why?
| | Patient Care Planning | 1 | 2016 | 143 | 0.130 |
Why?
| | Sex Distribution | 1 | 2016 | 351 | 0.130 |
Why?
| | Nurse's Role | 1 | 2016 | 102 | 0.130 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 195 | 0.130 |
Why?
| | Patient Selection | 1 | 2019 | 676 | 0.130 |
Why?
| | Aged, 80 and over | 3 | 2016 | 6561 | 0.130 |
Why?
| | Social Support | 2 | 2020 | 542 | 0.130 |
Why?
| | Multimedia | 1 | 2014 | 10 | 0.130 |
Why?
| | Factor X | 1 | 2014 | 25 | 0.130 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 79 | 0.130 |
Why?
| | Health Care Costs | 1 | 2018 | 394 | 0.130 |
Why?
| | Needs Assessment | 1 | 2016 | 327 | 0.130 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 142 | 0.130 |
Why?
| | Assisted Circulation | 1 | 2014 | 24 | 0.130 |
Why?
| | Program Development | 1 | 2016 | 357 | 0.120 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 301 | 0.120 |
Why?
| | Family Relations | 1 | 2015 | 85 | 0.120 |
Why?
| | Treatment Refusal | 1 | 2015 | 86 | 0.120 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 102 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1052 | 0.120 |
Why?
| | Sex Factors | 2 | 2016 | 1781 | 0.120 |
Why?
| | Length of Stay | 2 | 2017 | 1032 | 0.120 |
Why?
| | Patient Discharge | 2 | 2022 | 796 | 0.120 |
Why?
| | Population Surveillance | 1 | 2017 | 413 | 0.120 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1012 | 0.120 |
Why?
| | Cooperative Behavior | 1 | 2016 | 408 | 0.110 |
Why?
| | Risk | 1 | 2016 | 853 | 0.110 |
Why?
| | Heparin | 1 | 2014 | 230 | 0.110 |
Why?
| | Pain Management | 1 | 2016 | 294 | 0.110 |
Why?
| | Cohort Studies | 1 | 2023 | 5116 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 499 | 0.110 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 681 | 0.110 |
Why?
| | Program Evaluation | 1 | 2016 | 845 | 0.110 |
Why?
| | Antibodies | 1 | 2014 | 392 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2674 | 0.110 |
Why?
| | Pilot Projects | 1 | 2016 | 1419 | 0.100 |
Why?
| | Acute Disease | 1 | 2014 | 940 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1200 | 0.100 |
Why?
| | Patient Reported Outcome Measures | 2 | 2023 | 252 | 0.100 |
Why?
| | Motivation | 1 | 2015 | 506 | 0.100 |
Why?
| | Health Behavior | 1 | 2016 | 720 | 0.100 |
Why?
| | Prevalence | 1 | 2016 | 2326 | 0.090 |
Why?
| | Internet | 1 | 2014 | 633 | 0.090 |
Why?
| | Comorbidity | 3 | 2020 | 1527 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 992 | 0.090 |
Why?
| | Prognosis | 4 | 2018 | 3443 | 0.080 |
Why?
| | Disease Progression | 1 | 2016 | 2490 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2020 | 4596 | 0.080 |
Why?
| | Incidence | 1 | 2014 | 2424 | 0.080 |
Why?
| | Bayes Theorem | 2 | 2019 | 344 | 0.070 |
Why?
| | Academic Medical Centers | 2 | 2020 | 422 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2436 | 0.070 |
Why?
| | Disease Management | 2 | 2022 | 571 | 0.070 |
Why?
| | Young Adult | 2 | 2016 | 10793 | 0.060 |
Why?
| | Information Systems | 1 | 2023 | 66 | 0.060 |
Why?
| | Patient Care | 1 | 2023 | 105 | 0.050 |
Why?
| | Death | 1 | 2022 | 105 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 194 | 0.050 |
Why?
| | Role | 1 | 2020 | 32 | 0.050 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 2995 | 0.050 |
Why?
| | Hospitals, Community | 1 | 2020 | 49 | 0.050 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 54 | 0.050 |
Why?
| | Thromboembolism | 1 | 2021 | 99 | 0.050 |
Why?
| | Social Responsibility | 1 | 2020 | 46 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 119 | 0.040 |
Why?
| | Income | 1 | 2020 | 173 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 9 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 9 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 151 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 31 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 366 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2020 | 129 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4196 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 177 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 296 | 0.040 |
Why?
| | Survival | 1 | 2018 | 39 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 756 | 0.040 |
Why?
| | Walk Test | 1 | 2018 | 49 | 0.040 |
Why?
| | Time Factors | 2 | 2019 | 6412 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 254 | 0.040 |
Why?
| | Adolescent | 1 | 2016 | 18480 | 0.040 |
Why?
| | Viral Load | 1 | 2019 | 419 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 473 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2019 | 2235 | 0.040 |
Why?
| | Intraoperative Care | 1 | 2017 | 39 | 0.040 |
Why?
| | Equipment Design | 1 | 2019 | 519 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 380 | 0.040 |
Why?
| | Health Surveys | 1 | 2019 | 454 | 0.040 |
Why?
| | Nurses | 1 | 2019 | 142 | 0.040 |
Why?
| | Hemorrhage | 1 | 2021 | 623 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 4552 | 0.040 |
Why?
| | Frail Elderly | 1 | 2017 | 107 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 237 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 156 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1384 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 134 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 703 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 774 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 482 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 969 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1231 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 654 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1267 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 589 | 0.030 |
Why?
| | Stroke | 1 | 2021 | 1047 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1541 | 0.030 |
Why?
| | Telemedicine | 1 | 2020 | 664 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2016 | 586 | 0.030 |
Why?
| | Body Mass Index | 1 | 2019 | 2092 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 845 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1024 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1794 | 0.020 |
Why?
| | Child | 1 | 2022 | 19129 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|